Markets·June 18, 2026·3 min read

BMW Just Cut Guidance and Fell 8% — Falling Knife or Bargain?

Price · 12MYahoo Finance ↗

BMW closed around €62.24 on June 17, down about 8.3% after the company slashed its full-year 2026 guidance — cutting the auto EBIT margin target to roughly 4–6% and lowering pretax profit on weak China and U.S. demand. The move dragged the entire European auto sector down with it. The stock is now cheap, but it's cheap on a forecast that just got marked lower.

MetricValue
Close (Jun 17 2026)€62.24 (-8.3%)
52-week range€59 – €98
Trailing P/E~6x
Dividend yield~6.3%

The bull case

A guidance cut on a stock already down 20% on the year is often when the worst is finally in the price. BMW remains one of the best balance sheets and brands in autos, the dividend yields ~6.3%, and at ~6x earnings the bar is low. The pre-cut analyst average near €90 will be revised down, but even a haircut leaves meaningful theoretical upside if China stabilizes.

The bear case

Guidance cuts often travel in pairs — the first rarely captures the full deterioration, and the China weakness behind it is structural, not seasonal. A 4–6% auto margin is a sharp step down for a premium maker, and the dividend, while juicy, gets scrutinized the moment earnings fall. Catching a stock the day it warns is how value investors get hurt.

My verdict

This is a hold — let the knife land before reaching for it. The valuation is tempting and the dividend is real, but I don't buy into the first guidance cut; I wait for the reset to settle and for management to re-base expectations. As Ruslan Averin, my accumulation zone is the €55–€59 area, near and below the 52-week low, where the bad news is more fully discounted. At €62 on day one of the warning, patience beats bravery.

Bottom line: BMW is cheap with a 6.3% yield, but a fresh guidance cut is a falling knife — I'd wait for it to base near €58 rather than buy the warning at €62.

Ruslan Averin is an independent investor and market analyst, author of averin.com, publishing market research since 2014.

A
Ruslan AverinInvestor & Market Analyst

Writes on capital allocation, risk, and market structure.